Close it

Would you like to become a TBEC member? Please fill out the form below.

By becoming a TBEC member, you agree to endorse the values and the principles of the TB Europe Coalition, and agree with its membership rights and responsibilities.

Membership is free of charge.

TBEC membership rights

TBEC membership responsibilities












Posts tagged "WHO Europe"

Wolfheze Conference

The Wolfheze Conference takes place every other year, working to strengthen TB prevention and care in the WHO European Region and contribute to the elimination of TB. It is jointly organised by the WHO Regional Office for Europe, the European Centre for Disease Prevention and Control (ECDC) and the KNCV Tuberculosis Foundation. it will focus on the commitments made at the UN High-Level Meeting in 2018, to encourage countries in the region to turn these goals into actions. As part of the conference, the WHO Regional Office for Europe will also conduct its first joint meeting of the TB and HIV national programmes. This meeting will address the need for a coordinated response to both TB and HIV. For more information, contact coordinator@tbcoalition.eu.

WHO Europe Regional Collaborating Committee (RCC-THV) enlarged its mandate to cover HIV and viral hepatitis

WHO Europe Regional Collaborating Committee (RCC-THV) enlarged its mandate to cover HIV and viral hepatitis

On 11th of April, several TBEC Board and Secretariat members attended the 7th meeting of the Regional Collaborating Committee (RCC-THV), which recently enlarged its mandate to cover not only the Accelerated Response to Tuberculosis, but also to HIV and viral hepatitis. TBEC joined a group of international and regional civil society networks such as STOP TB Partnership, Global TB Caucus, TBPeople and the WHO Europe RCC-THV Secretariat and country officers. The meeting covered a variety of issues, starting from presentations on the implementation of regional action plans for HIV and TB, to WHO Europe engagement and contribution towards accountability framework post UN High-Level Meeting on TB to potential activities the RCC-THV could take on to support those WHO Europe region countries, currently transitioning from the Global Fund support to national funding. TBEC Board and Secretariat members not only actively engaged in discussions and group work, but also presented specific issues such as “Progress of the Review of Psycho-social support practices in the Region” by TBEC Board members, Safar Naimov and Oxana Ruscineanu, and “Access to Child TB drugs in the WHO region” by TBEC Secretariat. If you would be interested in more information on either of the two topics, please More…

Technical Advisory Group for Tuberculosis (TAG-TB) Europe Meeting

The Technical Advisory Group for Tuberculosis for the WHO European Region is holding its annual meeting in Copenhagen, Denmark. During this meeting, it will review progress made in implementing European TAG-TB and WHO advisory group  recommendations, as well as the status of the tuberculosis action plan for the WHO European Region 2016–2020. It will also advise on how member states can achieve greater progress and next steps within the region. For more information, contact coordinator@tbcoalition.eu.

Kyrgyzstan is implementing transition planning for TB and HIV

Kyrgyzstan is implementing transition planning for TB and HIV

A working group has brought together representatives from The Global Fund, government, civil society and communities to work on the transition. The Ministry of Health of Kyrgyzstan has formed a multi-disciplinary working group of specialists to plan, coordinate, and implement transition planning for TB and HIV. The group is already staffed by management, procurement, public health, and finance specialists. Representatives of civil society organizations and communities are also included. Other positions will be added. The working group will be assisted by a technical support group consisting of representatives from international organizations – the United Nations Office of Drugs and Crime, the World Health Organization, Open Society Foundations, UNAIDS – and communities. The representatives of CSOs and the communities are actively engaged at the decision-making level in the working group, and have suggested most of the initiatives that the working group has adopted, according to Aibar Sultangaziev, executive director of the Partnership Network, an association of 26 local CSOs. Consultation with the CSOs and the communities are ongoing. The discussion is focused mostly on service provision – in particular, which services should be covered, what elements should be included for each service, and how much they will cost. The working group More…

Kyrgyzstan Conducts "Gender and Legal Assessment in TB"

Kyrgyzstan Conducts “Gender and Legal Assessment in TB”

Kyrgyzstan is conducting “Gender and Legal Assessment in TB” with the support of Stop TB Partnership and the participation of international experts Nonna Turusbekova and Samanta Sokolowski. This kind of TB assessment is carried out for the first time. On the 2nd of December 2015, a round-table was held in Bishkek on the topic “Gender-based and Legal Assessment in Tuberculosis”. The Kyrgyz TB Coalition organized the event, which was attended by representatives of ministries, government services, and international and local civil society organizations. “Gender assessment consists of a series of steps aimed at assessing how differentiated the approach of TB programs is towards men, women, boys and girls, whereas legal assessment addresses issues of rights of Kyrgyz citizens, in general, and of key TB affected populations, in particular”, – explain international experts. As a result of discussions held on the 26th of January 2016, recommendations were made to amend the Law on Protection of Population from TB, currently under review by the Parliament of the Kyrgyz Republic. One of the suggested amendments is to ‘provide for interaction with civil society in the field of gender and other rights of persons affected by tuberculosis’. These recommendations, together with a letter of More…

Giving MDR-TB Patients a New Lease on Life

Giving MDR-TB Patients a New Lease on Life

Multidrug-resistant tuberculosis (MDR-TB) can be successfully treated today; however, the treatment course can take as long as two years and side effects can be severe if not appropriately addressed. The rate of MDR-TB treatment success is largely dependent on a patient’s socioeconomic circumstances as patients from marginalized groups are particularly vulnerable to dropping out of treatment. That is why ensuring patients’ adherence to TB treatment through a patient-centered approach that engages communities and civil society organizations, is critical to the success of MDR-TB treatment outcomes. Consistent with the principles of the WHO End TB Strategy, Project Hope’s interventions in Tajikistan (within the framework of the Global Fund to fight AIDS, Tuberculosis and Malaria TB grant) have provided a robust foundation for building a strong coalition in which communities and civil society organizations play a crucial role in combatting TB. Trained members of civil society and non-governmental organizations (NGO) have a unique capacity through patient education and psychosocial support to reach out to their communities to ensure that TB and MDR-TB patients make full recovery. One such patient for whom Project HOPE’s community-based initiatives were life-changing is Alisher Latipov. A family man from the Spitamen district in Tajikistan’s Sughd region, Alisher More…

HIV/TB Patients in Eastern Europe at higher risk of death than in Western Europe

HIV/TB Patients in Eastern Europe at higher risk of death than in Western Europe

The Lancet HIV Journal published a recent research study conducted by Daria Podlekareva and her colleagues that shows an alarming situation for people living with HIV and diagnosed with tuberculosis in Eastern Europe. They have a risk of death nearly four-times higher than patients from Western Europe and Latin America.   As mentioned in the study the reasons for the high mortality rate in Eastern Europe are complex and multifactorial. However, an urgent action is needed to improve tuberculosis care for patients living with HIV in this region. For full text and more details, please click here: Tuberculosis-related mortality in people living with HIV in Europe and Latin America: an international cohort study This blog is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020). The content of this blog represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use that may be made of the information More…

International course on clinical management of M(X)DR-TB for WHO Europe Region countries

International course on clinical management of M(X)DR-TB for WHO Europe Region countries

The WHO Collaborating Centre for Research and Training in Management of MDR-TB in Latvia announced an opportunity for clinicians and responsible for clinical managemnet of DR-TB to join their course. The main objective of the course is to update knowladge of the participants on the latest global development in M(X)DR-TB, as well as develop skills for M(X)DR-TB case management in their respective countries. The course will be available in Russian and English (according to schedule) and will last for 9 working days. For more details about the course please click here: International Advanced Course in clinical management of DR TB. Your completed application (click here: Application form WHO CC ) please send to the Tuberculosis Foundation of Latvia. E: info@ltbf.lv This blog is the product of an activity that has received funding under an operating grant from the European Union’s Health Programme (2014-2020). The content of this blog represents the views of the author only and is his/her sole responsibility; it cannot be considered to reflect the views of the European Commission and/or the Consumers, Health, Agriculture and Food Executive Agency or any other body of the European Union. The European Commission and the Agency do not accept any responsibility for use More…

TBEC participates in 63rd WHO Regional Committee for Europe

TBEC participates in 63rd WHO Regional Committee for Europe

On 16-19 September 2013, TBEC Steering Group member, Timur Abdullaev, attended the 63rd WHO Regional Committee for Europe in Turkey. Here he shares his thoughts on the event. In spite of outrageously beautiful weather and breathtaking views from the windows of the hotel there were very few empty seats in the conference room when the session started. As a representative of TB Europe Coalition with an observer status, I could easily flee to the beach and enjoy the sea. I have to be honest; I am not a great observer. I prefer to act and contribute; to participate rather than to attend. Call me insane, but I was among those civil society people who felt obliged to listen to sometimes boring speeches and to follow proposed changes to draft resolutions. On the first day, it was interesting to hear the report of the Regional Director; discussion of the WHO reform was also quite informative. On the second day, there was a discussion of the progress in implementation of Health 2020, and development of Health 2020 monitoring framework. I was concerned, however, that I was hearing very little from civil society and I asked myself whether my attendance was necessary. I More…

Civil Society: an important voice at Wolfheze Conference

Civil Society: an important voice at Wolfheze Conference

In our post yesterday we noted that, in comparison to previous years, this year’s Wolfheze Conference had a far greater number of civil society organisations participating. It was on this basis, and as a result of civil society organisations really be central in the fight against TB, that the TB Europe Coalition (TBEC) were asked to co-host and coordinate a session dedicated to the ‘Role of Civil Society in TB Control’. This session proved highly engaging with a wide-range of presentations from civil society organisations across the WHO European Region. Paul Sommerfeld, TB Alert, discussed not only the importance of CSOs but also obstacles that many face in carrying out their work. Carrying on with yesterdays theme, he spoke about the significance of TB partnerships and networks, such as TBEC, EHRN and the newly formed RICC-TB, and how valuable these can be in ensuring we speak in a collective and powerful voice.   Along with the introductory speech by Paul Sommerfeld, there were a range of other speakers from across the region. These included: Masha Tvaradze, Eurasian Harm Reduction Network (Lithuania); Darko Iliev, Medical and Ecological Research Centre of (Macedonia); Zahedul Islam, International HIV/AIDS Alliance (Ukraine); Denis Denisenko,Rinat Akhmetov Foundation More…

European Parliament launches a Written Declaration on drug-resistant tuberculosis in the European region

European Parliament launches a Written Declaration on drug-resistant tuberculosis in the European region

A Written Declaration (WD) on the threat of drug-resistant tuberculosis to the European region has been launched yesterday in the European Parliament. It contains recommendations calling on the European Commission and Council to financially and politically back the Global Fund 2013 replenishment and WHO Europe’s Roadmap on drug-resistant tuberculosis. It is backed by 14 MEPs from 6 different political groups and 10 different countries. If the Written Declaration gets the support of at least the majority of the Members of the European Parliament (i.e. 377 signatories) in 3 months’ time, it will be forwarded to the legislative and executive branch of the European Institutions for follow-up. The main objective of the WD is to raise awareness and campaign on the issue in the European Parliament. This could potentially pave the way for stronger legislation on DR-TB in the future. The Written Declaration is available in 23 European languages (see below) Written declaration on the threat of drug-resistant tuberculosis to the European region: Tuberculosis (TB) costs the European Union EUR 750 million per year and the European region is home to the highest rates of multidrug-resistant TB (MDR-TB) in the world, accounting for nearly 20 % of the global burden The More…

European Parliament discusses rise of multidrug-resistant tuberculosis in Europe

European Parliament discusses rise of multidrug-resistant tuberculosis in Europe

The following post is brought to you by Steve Lewis, the Global Health Advocacy Manager at RESULTS UK, who last week attended a hearing in European Parliament on ‘Funding crisis at the Global Fund to Fight AIDS, TB and Malaria and its impact on EU countries most affected by multi-drug resistant TB, in particular Romania’: Last week I was at a discussion in Parliament in Brussels during which European MEPs discussed the disturbing rise in TB in Eastern Europe. One of the worst hit countries is Romania where Romanian MEP Claudiu Tănăsescu told me, “When I used to work as a GP in Romania we believed that TB had been virtually eliminated. But this is not the case.” Information from various countries has been published recently in our report ‘Bridging the Gap – why the EU must address the funding crisis at the Global Fund to tackle HIV and TB epidemics in Eastern Europe and Central Asia’. The report includes case studies that demonstrate that without the resources to aggressively tackle these two diseases, the region risks undermining the progress made to date. Since the Global Fund to Fight AIDS, TB and Malaria was forced to cancel its last funding More…

wink.pink